NASDAQ:BGNE
Delisted

Beigene Stock Forecast

etoro logo Buy BGNE
*Your capital is at risk
$184.71
+0 (+0%)
At Close: Mar 28, 2025

BGNE Performance

FAQ

What is the symbol for BeiGene Ltd Stock and on which exchange is it traded?
The symbol for BeiGene Ltd is BGNE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BeiGene Ltd Stock?
BeiGene Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy BeiGene Ltd Stock?
BeiGene Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BeiGene Ltd Stock.

What's the current price of BeiGene Ltd Stock?
As of the end of day on the Mar 28, 2025, the price of an BeiGene Ltd (BGNE) share was $184.71.

What is the 52-week high and low for BeiGene Ltd Stock?
The 52-week high for BeiGene Ltd Stock is $248.16 and the 52-week low is $126.97.

What is the market capitalization of BeiGene Ltd Stock?
As of the Mar 28, 2025, the market capitalization of BeiGene Ltd is 20.209B.
Click to get the best stock tips daily for free!
ABOUT BEIGENE LTD
BeiGene
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tu...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE